Related Experiment Video
Updated: Aug 19, 2025

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes
Shohei Fukada1, Kouji Ohta2, Miyuki Sakuma1
1Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Objective:
Sunitinib, a targeted cancer drug, inhibits tyrosine kinases receptors and is widely used as first-line treatment for metastatic renal cell carcinoma. Patients undergoing chemotherapy with sunitinib frequently have oral mucosal complications, such as oral stomatitis, though cytotoxic effects of the drug on oral keratinocytes remain unknown.
Methods:
The effects of sunitinib on immortalized oral keratinocytes, RT7 cells, in regard to cell injury and apoptosis, as well as apoptosis-mediated signaling pathways were investigated.
Results:
Sunitinib treatment caused a significant increase in lactate dehydrogenase (LDH) in RT7 cells and primary oral keratinocytes. Additionally, the drug induced apoptosis-related events, such as DNA fragmentation, decreased anti-apoptotic Bcl-2 protein expression, and induction of cleaved PARP and caspase 3/9 in RT7 cells. Furthermore, phosphorylation of p38 MAPK, but not of ERK or JNK, was increased. On the contrary, constitutive phosphorylated STAT3 was decreased by sunitinib treatment, which was recovered by exposure to SB203580, a p38 MAPK inhibitor. Finally, SB203580 was found to reduce sunitinib-induced cell injury and apoptosis.
Conclusion:
The present results indicate that sunitinib promotes cell injury and apoptosis in oral keratinocytes via p38 activation and STAT3 downregulation. Sunitinib-mediated oral complications may be associated with cytotoxic effects of the drug on oral keratinocytes.
Insights
Sunitinib causes oral keratinocyte injury and apoptosis through p38 activation and STAT3 downregulation. These cytotoxic effects may explain sunitinib-related oral complications in cancer patients.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Sunitinib is a tyrosine kinase inhibitor used for metastatic renal cell carcinoma.
- Oral mucosal complications like stomatitis are common in patients treated with sunitinib.
- The cytotoxic effects of sunitinib on oral keratinocytes are not well understood.
Purpose of the Study:
- To investigate the effects of sunitinib on oral keratinocytes.
- To elucidate the mechanisms of sunitinib-induced cell injury and apoptosis.
- To identify the signaling pathways involved in sunitinib's effects on oral keratinocytes.
Main Methods:
- Sunitinib's effects on immortalized oral keratinocytes (RT7 cells) and primary oral keratinocytes were assessed.
- Cell injury was measured by lactate dehydrogenase (LDH) release.
- Apoptosis was evaluated through DNA fragmentation, protein expression (Bcl-2, PARP, caspases), and Western blotting for signaling pathways (MAPK, STAT3).
Main Results:
- Sunitinib significantly increased LDH release, indicating cell injury.
- The drug induced apoptosis, evidenced by DNA fragmentation and altered expression of apoptosis-related proteins (Bcl-2, PARP, caspase 3/9).
- Sunitinib increased p38 MAPK phosphorylation, decreased STAT3 phosphorylation, and these changes were linked to cell injury and apoptosis.
Conclusions:
- Sunitinib induces cell injury and apoptosis in oral keratinocytes.
- The mechanism involves p38 MAPK activation and STAT3 downregulation.
- These findings suggest sunitinib's cytotoxic effects on oral keratinocytes contribute to oral complications during cancer therapy.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...